相关实验视频

Updated: Jul 13, 2025

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on: November 22, 2024

在中发现了新型氨抑制剂,使用基于联体的3D药模拟和分子动力学模拟

Nivya R M¹, Amitha Joy¹

¹Department of Biotechnology Engineering, Sahrdaya College of Engineering and Technology, APJ Abdul Kalam Technological University of Kerala, Thrissur, Kerala, India.

Journal of biomolecular structure & dynamics

|October 18, 2023

概括

这项研究使用计算建模识别了五种新型氨尿素抑制剂 (CnI),用于潜在的神经退行性疾病治疗. 这些分子显示出有前途的结合亲和力和稳定性,这表明了新的治疗途径.

科学领域:

生物化学生物化学
神经科学是一个神经科学.
计算化学计算化学

背景情况:

氨酸是细胞信号传递中的关键酶,涉及到平衡,发育和疾病.
Ca2+/calcineurin/NFAT通路的失调与自身免疫和神经退行性疾病有关.
现有的氨酸抑制剂 (CnI),如环素A和塔克罗利,是免疫抑制剂,但它们在神经保护方面的潜力正在出现.

研究的目的:

在神经退行性疾病中的潜在治疗应用中,以计算方式识别新型氨酸抑制剂 (CnI).
通过分子对接和动态模拟来验证已识别的潜在CNI的有效性和稳定性.

主要方法:

使用已知的CNI (CsA,FK506) 构建基于体的3D药模拟来构建预测模型.
药模型与大型化学数据库 (PubChem,ChemSpider等) 进行了选. 为了识别潜在的命中.
包括分子对接,药理动力学性质预测,分子动力学模拟和毒性评估在内的in silico方法在选择的命中中进行.

主要成果:

总共有440个潜在的匹配结果被从数据库选中确定.
五个分子 (ILB 162,ILB 005,ILB 439,ILB 390,和ILB 198) 显示出显著的结合亲和力 (-9.7到 -9.0 Kcal/mol) 氨酸 (PDB: 1MF8).
分子动力学模拟证实了这五种分子与尿素的稳定性和持续相互作用.

结论:

已识别的分子代表了有前途的新型氨抑制剂,具有治疗神经退行性疾病的治疗剂的潜力.
在的药物发现方法,包括药模拟和分子动力学,对于识别新药候选者是有效的.
需要进一步的实验验证,以确认这些新型CNI在神经退行性疾病模型中的治疗疗效.

关键词:

血液大脑屏障透性透气性联系人侦察员必不可少的 4.4 分子对接研究研究.神经退行性疾病的神经退行性疾病

更多相关视频

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

相关概念视频

Ligand Binding Sites

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...